Neogen Chemicals shareholders approve all resolutions at 37th AGM

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Neogen Chemicals published consolidated voting results for its 37th AGM held on August 21, 2026
  • All five resolutions were passed, including a special resolution to authorize securities issuance
  • The fundraising authorization received 98.74% support with 2,57,405 votes against
  • Total votes cast across all resolutions amounted to 2,04,30,722
  • Shareholders approved a final dividend of ₹1 per equity share and reappointed Dr. Harin Kanani
powered bylight_fuzz_icon
48869275

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited published the consolidated voting results and scrutinizer’s report for its 37th Annual General Meeting (AGM) held on August 21, 2026. Shareholders approved all five agenda items, including a special resolution to authorize future fundraising.

The meeting, conducted via Video Conferencing or Other Audio-Visual Means (VC/OAVM), commenced at 5:00 pm and concluded at 6:31 pm. Unnati Kanani, Company Secretary and Compliance Officer, confirmed that the requisite quorum was present. CS Devendra Deshpande of DVD & Associates served as the independent scrutinizer for the e-voting process.

Resolutions Approved

Members voted on five agenda items during the session. The ordinary business included adopting the audited standalone and consolidated financial statements for FY26 and reappointing Dr. Harin Kanani as Managing Director. The special business involved authorizing future fundraising.

Resolution Type Description Status
Ordinary Adopt Audited Financial Statements for FY26 Passed
Ordinary Declare Final Dividend of ₹1 per share Passed
Ordinary Reappointment of Dr. Harin Kanani Passed
Special Authorize Issuance of Securities Passed
Ordinary Ratify Cost Auditor Remuneration Passed

Voting Details

The total number of votes cast across all resolutions was 2,04,30,722. Voting was conducted through remote e-voting and electronic voting during the AGM facility provided by MUFG Intime India Private Limited.

The resolution to authorize the issuance of securities through permissible modes of fund-raising secured 98.74% of valid votes in favor, with 2,57,405 votes cast against. All other ordinary resolutions received unanimous or near-unanimous support.

Management Discussion

Dr. Harin Kanani briefed members on the company’s financial performance and future growth plans. He noted that the Statutory Auditors’ Report and Secretarial Auditors’ Report contained no qualifications or adverse comments.

Shareholders raised questions regarding revenue, profit, EBITDA, and Return on Capital Employed (ROCE) growth projections for the next three to five years. Other topics included the expected revenue contribution from new battery material products, the capacity of the Dahej Replacement Plant, and the commissioning status of the Pakhajan Facility.

Investors also inquired about Non-FEOC compliance, pricing of battery materials, benefits from Production Linked Incentive (PLI) schemes, and the joint venture with Morita Investment Limited. Further queries covered the downgrade in credit rating, annual interest burden, control measures, and insurance claim status following the fire incident at the Dahej SEZ Plant.

Dr. Kanani provided clarifications on these matters, including details on R&D expenses, Corporate Social Responsibility (CSR) spend, performance in core specialty chemicals, and the impact of AI usage on business operations.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.28%+4.26%+2.18%+68.09%+55.41%+134.17%

How will the authorized issuance of securities impact Neogen Chemicals' debt-to-equity ratio and future capital allocation strategies?

What is the projected timeline for the full operational commissioning of the Pakhajan Facility and its expected contribution to FY27 revenue?

How does management plan to mitigate the financial impact of the Dahej plant fire insurance claim delays on short-term cash flows?

SBI Mutual Fund reduces Neogen Chemicals stake to 6.03% under SAST Reg 29

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

SBI Mutual Fund sold 2,11,931 shares of Neogen Chemicals on August 18, 2026, reducing its stake to 6.0280%. The move was disclosed under Regulation 29 of SEBI SAST Regulations, reflecting a decline from the prior holding of 6.8019%. No encumbrances were attached to the remaining shares.

powered bylight_fuzz_icon
48749038

*this image is generated using AI for illustrative purposes only.

SBI Mutual Fund has reduced its stake in Neogen Chemicals following a market sale of over 2 lakh shares on August 18, 2026. The mutual fund, acting through its various schemes, disposed of 2,11,931 equity shares, bringing its total holding down to 16,50,555 shares.

The disposal was formally disclosed pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing indicates that the shareholding decreased by 2% from the previous disclosure threshold, with the reported holding falling from 8.5930% in an earlier notification to the current level. As a result of the August 18 transaction, SBI Mutual Fund's shareholding in the chemical manufacturer fell to 6.0280% of the paid-up share capital. This represents a decrease from the immediately preceding disclosed holding of 6.8019%, which comprised 18,62,486 shares.

Transaction Details

The disposal was executed via an open market sale. There were no encumbrances, pledges, or voting rights other than those attached to the equity shares involved in the transaction. The company's total equity share capital remained unchanged at ₹27,38,16,740, consisting of 2,73,81,674 equity shares with a face value of ₹10 each.

Metric Before Sale Sale Details After Sale
Shares Held 18,62,486 Sold 2,11,931 16,50,555
Shareholding % 6.8019% Decrease of 0.7740% 6.0280%
Mode of Trade N/A Market Sale N/A

What the Numbers Show

The reduction in SBI Mutual Fund's stake indicates a partial exit or rebalancing within its portfolio allocations for Neogen Chemicals. The drop from 6.8019% to 6.0280% suggests the fund is maintaining a significant but reduced exposure to the stock, staying above the 5% threshold that typically triggers substantial acquisition disclosures under SEBI regulations. The absence of any pledge or encumbrance on the remaining shares indicates a clean holding structure post-transaction.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.28%+4.26%+2.18%+68.09%+55.41%+134.17%

Will SBI Mutual Fund continue to reduce its stake in Neogen Chemicals in subsequent quarters, or is the current 6.0280% holding considered a strategic long-term position?

How might this institutional selling pressure impact Neogen Chemicals' stock price volatility and trading volume in the short term?

Are other major institutional investors or mutual funds likely to follow suit and rebalance their portfolios away from Neogen Chemicals?

More News on Neogen Chemicals

1 Year Returns:+55.41%